Odyssey Health (ODYY) Profit After Tax Growth (5y) (2019 - 2026)
Odyssey Health (ODYY) Profit After Tax Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 16.00% |
| Jan 31, 2026 | -32.88% |
| Oct 31, 2025 | 7.44% |
| Jul 31, 2025 | 28.33% |
| Apr 30, 2025 | 24.10% |
| Jan 31, 2025 | 18.20% |
| Oct 31, 2024 | 6.38% |
| Jul 31, 2024 | 11.29% |
| Apr 30, 2024 | -68.09% |
| Jan 31, 2024 | 163.37% |
| Oct 31, 2023 | -50.58% |
| Jul 31, 2023 | -52.44% |
| Apr 30, 2023 | -77.17% |
| Jan 31, 2023 | -46.56% |
| Oct 31, 2022 | -102.32% |
| Jul 31, 2022 | -98.68% |
| Apr 30, 2022 | -107.79% |
| Jan 31, 2022 | -122.31% |
| Oct 31, 2021 | -137.32% |
| Jul 31, 2021 | -139.47% |